Junyan Shi1, Edwin G Lindo2, Geoffrey S Baird1, Bessie Young3, Michael Ryan4, J Ashley Jefferson4, Rajnish Mehrotra3, Patrick C Mathias5, Andrew N Hoofnagle6. 1. Department of Laboratory Medicine and Pathology; University of Washington, School of Medicine, United States. 2. Department of Family Medicine; Department of Bioethics & Humanities; Office of Healthcare Equity; University of Washington, School of Medicine, United States. 3. Kidney Research Institute, Division of Nephrology, Department of Medicine; University of Washington, School of Medicine, United States. 4. Division of Nephrology, Department of Medicine; University of Washington, School of Medicine, United States. 5. Department of Laboratory Medicine and Pathology; Department of Biomedical Informatics and Medical Education; University of Washington, School of Medicine, United States. 6. Department of Laboratory Medicine and Pathology; Kidney Research Institute; Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine; University of Washington, School of Medicine, United States. Electronic address: ahoof@uw.edu.
Abstract
BACKGROUND AND AIMS: Creatinine-based MDRD and CKD-EPI equations include a race correction factor, which results in higher eGFR in Black patients. We evaluated the impact on our patient population upon adoption of the CKD-EPI equation and the removal of the race correction factor from the equation. MATERIALS AND METHODS: Retrospective analysis of blood creatinine results and respective eGFR values calculated by the MDRD or CKD-EPI equation without the race correction factor (CKD-EPINoRace) in a large academic medical system over a 20.5-month period. RESULTS: In our population, when changing from MDRD to CKD-EPINoRace, we observed that 3.5% of all patients were reclassified to categorically have worse kidney function. However, we also observed fewer patients overall with eGFR below 60 mL/min/1.73 m2. Around 60 and 20 mL/min/1.73 m2, 2.96% and 0.16% of all patients > 65 years of age were reclassified, as were 4.29% and 0.03% of all Black patients, respectively. When calculated with CKD-EPINoRace, median eGFR was not meaningfully different between Black and non-Black patients (p = 0.02). CONCLUSIONS: Changing from MDRD to CKD-EPINoRace could lead to a lower referral rate to nephrology. The distributions of creatinine and eGFR calculated with CKD-EPINoRace were not meaningfully different in Black and non-Black patients.
BACKGROUND AND AIMS: Creatinine-based MDRD and CKD-EPI equations include a race correction factor, which results in higher eGFR in Black patients. We evaluated the impact on our patient population upon adoption of the CKD-EPI equation and the removal of the race correction factor from the equation. MATERIALS AND METHODS: Retrospective analysis of blood creatinine results and respective eGFR values calculated by the MDRD or CKD-EPI equation without the race correction factor (CKD-EPINoRace) in a large academic medical system over a 20.5-month period. RESULTS: In our population, when changing from MDRD to CKD-EPINoRace, we observed that 3.5% of all patients were reclassified to categorically have worse kidney function. However, we also observed fewer patients overall with eGFR below 60 mL/min/1.73 m2. Around 60 and 20 mL/min/1.73 m2, 2.96% and 0.16% of all patients > 65 years of age were reclassified, as were 4.29% and 0.03% of all Black patients, respectively. When calculated with CKD-EPINoRace, median eGFR was not meaningfully different between Black and non-Black patients (p = 0.02). CONCLUSIONS: Changing from MDRD to CKD-EPINoRace could lead to a lower referral rate to nephrology. The distributions of creatinine and eGFR calculated with CKD-EPINoRace were not meaningfully different in Black and non-Black patients.
Authors: Cynda Ann Johnson; Andrew S Levey; Josef Coresh; Adeera Levin; Joseph Lau; Garabed Eknoyan Journal: Am Fam Physician Date: 2004-09-01 Impact factor: 3.292
Authors: James A Diao; Lesley A Inker; Andrew S Levey; Hocine Tighiouart; Neil R Powe; Arjun K Manrai Journal: N Engl J Med Date: 2021-01-06 Impact factor: 91.245
Authors: Gary L Myers; W Greg Miller; Josef Coresh; James Fleming; Neil Greenberg; Tom Greene; Thomas Hostetter; Andrew S Levey; Mauro Panteghini; Michael Welch; John H Eckfeldt Journal: Clin Chem Date: 2005-12-06 Impact factor: 8.327
Authors: Lesley A Inker; Brad C Astor; Chester H Fox; Tamara Isakova; James P Lash; Carmen A Peralta; Manjula Kurella Tamura; Harold I Feldman Journal: Am J Kidney Dis Date: 2014-03-16 Impact factor: 8.860
Authors: Salman Ahmed; Cameron T Nutt; Nwamaka D Eneanya; Peter P Reese; Karthik Sivashanker; Michelle Morse; Thomas Sequist; Mallika L Mendu Journal: J Gen Intern Med Date: 2020-10-15 Impact factor: 5.128
Authors: Cynthia Delgado; Mukta Baweja; Nilka Ríos Burrows; Deidra C Crews; Nwamaka D Eneanya; Crystal A Gadegbeku; Lesley A Inker; Mallika L Mendu; W Greg Miller; Marva M Moxey-Mims; Glenda V Roberts; Wendy L St Peter; Curtis Warfield; Neil R Powe Journal: J Am Soc Nephrol Date: 2021-04-09 Impact factor: 14.978